Paion AG (PAIOF)
OTC
Real-time Data
01:30 PM
Day's Range
0.070052 wk Range
0.000100Overview - PAIOF - Paion AG
Key Statistics
Valuation
Enterprise Value
19.96M
P/E (Trailing)
‪-0.87‬
PEG Ratio
‪0.0064‬
Price / Sales (TTM)
‪0.03‬
Price / Book
‪-0.14‬
EV / EBITDA
‪-1.08‬
Profitability
Gross Margin
‪33.24%‬
Profit Margin
‪-134.11%‬
Operating Margin
‪-83.59%‬
Return on Assets
‪-27.07%‬
Return on Equity
‪-288.71%‬
Ownership
Shares Outstanding
7.13M
Float
6.48M
Held by Insiders
‪0.00%‬
Held by Institutions
‪1.15%‬
Price stats
Beta
‪4.14‬
50-Day Avg
‪0.0424‬
200-Day Avg
‪0.0181‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - PAIOF - Paion AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - PAIOF - Paion AG
About
Paion AG is a specialty pharmaceutical company focused on developing and commercializing innovative drugs for the treatment of patients in anesthesia and critical care settings. The primary objective of Paion AG is to address the needs of anesthesiologists and increase the options available for effective patient…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
